Navigation Links
Hookworms in MS trial
Date:3/3/2009

Scientists from The University of Nottingham will study the potential health benefits of parasitic worms as part of a study investigating treatments for people with the autoimmune condition multiple sclerosis (MS).

It is thought that hookworms may play a role in damping down the immune system, which is overactive in people with MS, the most disabling neurological condition in young adults.

The 400,000, three-year project funded by the MS Society, aims to determine whether infection with a small and harmless number of the worms can lead to an improvement on the severity of MS over a 12 month period.

If the trial is successful, the worms have the potential to provide a simple, cheap, natural and controllable treatment for MS.

The WIRMS (Worms for Immune Regulation in MS) study is led by Professor Cris Constantinescu and Professor David Pritchard and is a randomised, placebo controlled, phase 2 study in people with relapsing remitting MS and will be carried out at multiple centres up and down the country.

The 25 worms are microscopic and are introduced painlessly through a patch in the arm. They are then flushed out after nine months.

Professor Constantinescu, said: "People are really interested in this form of potential therapy because it's a natural treatment. It's been tested for safety and we now need to study the potential benefits and any side effects."

Jayne Spink, Director of Research at the MS Society said: "It sounds like science fiction, but it has been shown in a previous small study that people with MS who also had gut parasite infections had fewer relapses.

"Over time, parasitic worms have evolved to be able to survive an immune system attack and have been linked to a reduction in the severity of the symptoms of MS, which can be debilitating.

"If the theories can be shown to be accurate, using hookworms as a future treatment option may prove to be science fact."

'/>"/>
Contact: Professor Cris Constantinescu
cris.constantinescu@nottingham.ac.uk
44-011-584-66597
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
2. CANTAM first African Network of Excellence for clinical trials
3. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials
4. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
5. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
6. Laser Therapy Disappoints in Stroke Trial
7. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
8. Many Clinical Trials Moving Overseas
9. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
10. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
11. Bradmer provides clinical trial update and announces evaluation of strategic alternatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... North American Seminars Inc. is now ...tinuing medical education courses at their medical...to showcase its operation and capabilities to the ...costs to educate their physical therapy and occupa...ities hosted over 250 live training events. , ...
(Date:12/4/2009)... OAKLAND, Calif., Dec. 4 Herpes zo...hildren who have been vaccinated against chicken p...December issue of the Pediatric Infectious Diseas...ind, used electronic health records to identify mo...ella (chicken pox) vaccine from 2002 to 2008 in Ka...
(Date:12/3/2009)...OUTHBRIDGE, Mass., Dec. 3 The Ca... treat its first patients, Harrington Hospital ann...ients immediately," said Diane Becquart, Director ...oval was granted today by the Massachusetts Depart...ty review of the facility. ,, The opening of T...
(Date:12/3/2009)... CHICAGO, Dec. 3 The Am...hat the United States District Court for the South...pproval of the previously disclosed $350 million s...t against UnitedHealth Group. ,, The action bro...ew York and Missouri State Medical Association, al...
(Date:12/3/2009)...tperforms widely used sulfonylureas, but each pati...HURSDAY, Dec. 3 (HealthDay News) -- A class of dr...diabetes is associated with a higher risk of dying...min, researchers say. , , Sulfonylureas, long a...ll than metformin in a study of oral anti-diabetes...
Breaking Medicine News(10 mins):Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3
...ee hospitals operated by,ParkwayHealth have become...in a U.S.-based health care network and will treat...ates that are dramatically lower than those,typica... Mount Elizabeth, Gleneagles or East Shore,hospita...
...ely as girls in the U.S. and Asia (mostly Japan) t...for growth hormone deficiency, illnesses that affe...re. A smaller gender difference exists in Europe, ...ale height in some countries. , The study, by res...
...etrical data management system integrates system, ...tes documentation and, compliance, and supports pa... outcomes., BATESVILLE...learance from the U.S. Food and,Drug Administratio...
...N, Del., April 17 ,Washington University School of...any AstraZeneca (NYSE: AZN ) have announced a res...mproved ways to diagnose and,treat Alzheimer,s dis...Alzheimer,s disease and track its response to trea...
...r treatment using microscopic magnets to enable ,a...oped by researchers funded by the Biotechnology an...search published online today (17 April) in the jo...ng and invading malignant tumours. , Using human ...
...ens Health ,Burnham Institute for Medical Rese...Research Center at a ceremony on Burnhams campus o...ctor of the center, will introduce the newly appoi...e center was made possible by a $20 million donati...
Other Medicine News:Health News:Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S. 2Health News:Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S. 3Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 2Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 3Health News:Hill-Rom's NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care 2Health News:Washington University in St. Louis and AstraZeneca Announce Alzheimer's Research Collaboration 2Health News:Washington University in St. Louis and AstraZeneca Announce Alzheimer's Research Collaboration 3Health News:Washington University in St. Louis and AstraZeneca Announce Alzheimer's Research Collaboration 4Health News:Tiny magnets offer breakthrough in gene therapy for cancer 2Health News:Recent developments at the Burnham Institute 2
(Date:12/3/2009)...2009 Raytheon BBN Technologies, a ... RTN ), has licensed its patented, award-winning...JIFILM Corp. ,, FUJIFILM intends to interface ... Combined with SDM technology, the Aspire HD digit...or 3-D viewing. FUJIFILM will display the Raytheon...
(Date:12/3/2009)...3 Upsher-Smith Laboratories, Inc. ...an for central nervous system (CNS) diseases with ...y developed program for the management of epilepsy...oprietary formulation technology and will enter a ...unctive treatment of epilepsy patients with partia...
(Date:12/3/2009)...wswire-USNewswire/ -- New state investments will h... a new cold storage facility and help a Philadelph...ile creating at least 20 jobs, Governor Edward G. ...dustrial Development Authority yesterday approved ...estments, in the form of low-interest loans, will ...
Breaking Medicine Technology:Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 2Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference 6355 1Cancer patients and doctors report drug side effects differently 61571 1Cancer patients and doctors report drug side effects differently 61571 2When East meets West 3A Why consumers turn to alternative medicine 61567 1When East meets West 3A Why consumers turn to alternative medicine 61567 2
...utical,Research and Manufacturers of America (PhRM...arch pipeline for major diseases affecting African...oday. The report found,that America,s pharmaceutic...cines to help treat diseases that disproportionate...mong the top 10 causes of death among,African Amer...
...oxaparin sodium injection) were also less l..., BRIDGEWATER, N.J., Dec 10 Sanofi-aventis,annou...d total hospital,direct medical costs associated w...when they were treated with the use of low-molecul...n (UFH) with 97.3% of LMWH patients,receiving Love...
Other Medicine Technology:New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 2New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5
BTC/1Q - Cast Aluminum Base - Model 1Q53-R
BTC/1Q - Cast Aluminum Base - Model 1Q52-R
BTC/1Q - Cast Aluminum Base - Model 1Q70
BTT/1P - Tubular Base - Model 1P62-R
Medicine Products: